1. Rohan, M, Parow, A, Stoll, AL, Demopulos, C, et al. Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry. 2004; 161(1): 93–98.
2. Rohan, ML, Yamamoto, RT, Ravichandran, CT, et al. Rapid mood-elevating effects of low field magnetic stimulation in depression. Biol Psychiatry. 2014; 76(3): 186–193.
3. Carlezon, WA, Rohan, ML, Mague, SD, et al. Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol Psychiatry. 2005; 57(6): 571–576.
4. Shafi, M, Stern, AP, Pascual-Leone, A. Adding low field magnetic stimulation to noninvasive electro-magnetic neuromodulatory therapies. Biol Psychiatry. 2014; 76(3): 170–171.
5. Leuchter, AF, Cook, IA, Jin, Y, Phillips, B. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci. 2013; 7: 37.
6. Leuchter, AF, Cook, IA, Feifel, D, et al. Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimul. 2015; 8(4): 787–794.
7. Kammer, T, Spitzer, M. Brain stimulation in psychiatry: methods and magnets, patients and parameters. Curr Opin Psychiatry. 2012; 25(6): 535–t41.
8. Peng, DT, Zhu, R, Yuan, XR, Zhang, X. Clinical study of deep brain magnetic stimulation technique in the treatment of Alzheimer’s disease [in Chinese]. Chin J Geriatr. 2012; 31(11): 929–931.
9. Zhang, Y, Mao, RR, Chen, ZF, et al. Deep-brain magnetic stimulation promotes adult hippocampal neurogenesis and alleviates stress-related behaviors in mouse models for neuropsychiatric disorders. Mol Brain. 2014; 7: 11.
10. Garcia-Toro, M, Montes, JM, Talavera, JA. Functional cerebral asymmetry in affective disorders: new facts contributed by transcranial magnetic stimulation. J Affect Disord. 2001; 66(2–3): 103–109.
11. Burt, T, Lisanby, SH, Sackeim, HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002; 5(01): 73–103.
12. Gershon, AA, Dannon, PN, Grunhaus, L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003; 160(5): 835–845.
13. Thut, G, Veniero, D, Romei, V, Miniussi, C, Schyns, P, Gross, J. Rhythmic TMS causes local entrainment of natural oscillatory signatures. Curr Biol. 2011; 21(14): 1176–1185.
14. Veniero, D, Brignani, D, Thut, G, Miniussi, C. Alpha-generation as basic response-signature to transcranial magnetic stimulation (TMS) targeting the human resting motor cortex: a TMS/EEG co-registration study. Psychophysiology. 2011; 48(10): 1381–1389.
15. Sadaghiani, S, Scheeringa, R, Lehongre, K, Morillon, B, Giraud, AL, Kleinschmidt, A. Intrinsic connectivity networks, alpha oscillations, and tonic alertness: a simultaneous electroencephalography/functional magnetic resonance imaging study. J Neurosci. 2010; 30(30): 10243–10250.
16. Xiao, L, Feng, Y, Feng, L, Hu, C, Zhang, G, Wang, G. Effects of deep-brain magnetic stimulation on brain derived neurotrophic factor in treatment-resistant depression [in Chinese]. J Clin Psychiatry. 2015; 25(6): 361–364.
17. Jin, Y, Phillips, B. A pilot study of the use of EEG-based synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. BMC Psychiatry. 2014; 14: 13.
18. Park, H, Poo, M. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013; 14(1): 7–23.
19. Groves, JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 2007; 12(12): 1079–1088.
20. Adachi, M, Barrot, M, Autry, AE, Theobald, D, Monteggia, LM. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry. 2008; 63(7): 642–649.
21. Duman, RS, Monteggia, LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006; 59(12): 1116–1127.
22. Brunoni, AR, Lopes, M, Fregni, F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008; 11(8): 1169.
23. Sen, S, Duman, R, Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008; 64(6): 527–532.
24. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56–62.
25. Xie, GR, Shen, QJ. Use of the Chinese version of the Hamilton Rating Scale for Depression in general population and patients with major depression. Chin J Nerv Ment Dis. 1984; 10: 364.
26. Hamilton, M. The assessment of anxiety states by rating. Br J Psychiatry. 1959; 32(1): 50–55.
27. Guy, W. Clinical global impressions. In. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute for Mental Health; 1976: 218–222.
28. Trivedi, MH, Rush, AJ, Wisniewski, SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006; 163(1): 28–40.
29. Greenhouse, SW, Geisser, S. On methods in the analysis of profile data. Psychometrika. 1959; 24(2): 95–112.
30. Citrome, L. Number needed to treat: what it is and what it isn’t, and why every clinician should know how to calculate it. J Clin Psychiatry. 2011; 72(3): 412–413.
31. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
32. Pan, W, Banks, WA, Fasold, MB, Bluth, J, Kastin, AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998; 37(12): 1553–1561.
33. Sartorius, A, Hellweg, R, Litzke, J, et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry. 2009; 42(6): 270–276.
34. Wang, HY, Crupi, D, Liu, J, et al. Repetitive transcranial magnetic stimulation enhances BDNF–TrkB signaling in both brain and lymphocyte. J Neurosci. 2011; 31(30): 11044–11054.
35. Yukimasa, T, Yoshimura, R, Tamagawa, A, et al. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry. 2006; 39(2): 52–59.
36. Zanardini, R, Gazzoli, A, Ventriglia, M, et al. Effect of repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor in drug resistant depressed patients. J Affect Disord. 2006; 91(1): 83–86.
37. Lang, C, Schüler, D. Biogenic nanoparticles: production, characterization, and application of bacterial magnetosomes. J Phys Condens Matter. 2006; 18(38): S2815–S2828.
38. Gedge, L, Beaudoin, A, Lazowski, L, du Toit, R, Jokic, R, Milev, R. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry. 2012; 3: 12.
39. Angelucci, F, Oliviero, A, Pilato, F, et al. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport. 2004; 15(4): 717–720.
40. Rusovan, A, Kanje, M, Mild, KH. The stimulatory effect of magnetic fields on regeneration of the rat sciatic nerve is frequency dependent. Exp Neurol. 1992; 117(1): 81–84.
41. Volkow, ND, Tomasi, D, Wang, GJ, et al. Effects of low-field magnetic stimulation on brain glucose metabolism. NeuroImage. 2010; 51(2): 623–628.
42. Rokni-Yazdi, H, Sotoudeh, H, Akhondzadeh, S, Sotoudeh, E, Asadi, H, Shakiba, M. Antidepressant-like effect of magnetic resonance imaging-based stimulation in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(2): 503–509.
43. Drevets, WC, Price, JL, Furey, ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008; 213(1–2): 93–118.
44. Leuchter, AF, Cook, IA, Hunter, AM, Cai, C, Horvath, S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One. 2012; 7(2): e32508.